NCT02800889View on ClinicalTrials.gov

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 24, 2016

Primary Completion Date

July 10, 2018

Study Completion Date

July 10, 2018

Conditions
LymphomaSolid Tumor (Excluding CNS)
Interventions
DRUG

Pixantrone

Pixantrone

Trial Locations (1)

90027

Children's Hospital Los Angeles, Los Angeles

Sponsors

Lead Sponsor

CTI BioPharma
All Listed Sponsors
lead

CTI BioPharma

INDUSTRY